Global Recombinant Proteins Market Growth Prospects and Strategic Opportunities Through 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Recombinant Proteins Market Expected To Grow In Terms Of Size?
In recent times, the market size for recombinant proteins has seen significant growth. It is forecasted to escalate from $2.31 billion in 2024 to $2.55 billion in 2025, with a compound annual growth rate (CAGR) of 10.5%. Factors such as the increasing need for biopharmaceuticals, a surge in chronic disease cases, an expanding elderly population, government actions and funding, as well as broader applications in research and diagnostics, have contributed to the growth during the historical period.
Anticipated to surge at an impressive compound annual growth rate (CAGR) of 13.6%, the recombinant proteins market size is forecasted to expand to a value of $4.25 billion by 2029. This projected advancement over the period can be accredited to factors such as the growing preference for individualized medicine, robust enhancement of the biotechnology industry, international initiatives towards rare disease treatment, and advancements in protein engineering techniques. Emerging markets and untapped potential also contribute to this growth. The period is expected to witness increased focus on expanding personalized medicine, significant advancements in the biotechnology industry, intensified demand for therapeutic proteins, discovery of innovative therapeutic targets, and a global emphasis on vaccine development.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9959&type=smp
Which Key Factors Are Fueling Growth In The Recombinant Proteins Market?
The accelerated focus on personally tailored medicine is predicted to stimulate the development of the recombinant protein market. Personalized medicine adopts a medical strategy that customizes treatments and therapies to the individual specifics, genetics, and requirements of every patient, with the aim of delivering more precise and targeted healthcare outcomes. The expansion of personalized medicine is credited to advancements in genomic technologies and data analytics, facilitating therapies based on unique genetic profiles. By providing for the creation of customized therapies addressing an individual’s distinct genetic and molecular profile, recombinant proteins foster personalized medicine, improving treatment efficiency and reducing adverse effects. For instance, in February 2024, as per the Personalized Medicine Coalition, a U.S.-based non-profit organization, the FDA sanctioned 16 new personalized treatments for patients suffering from rare diseases in 2023, a substantial rise from six in 2022. Thus, the intensified focus on personalized medicine is fueling the growth of the recombinant protein market in the future.
How Is The Recombinant Proteins Market Categorized Across Applications And Types?
The recombinant proteinsmarket covered in this report is segmented –
1) By Product: Antibodies, Cytokines, Immune Checkpoint Protein, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products
2) By Application: Drug And Discovery Development, Therapeutics, Research, Other Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies
2) By Cytokines: Interleukins, Interferons, Tumor Necrosis Factors (TNFs)
3) By Immune Checkpoint Proteins: PD-1 Or PD-L1 Inhibitors, CTLA-4 Inhibitors
4) By Virus Antigens: Viral Capsid Proteins, Envelope Proteins
5) By Enzymes: Restriction Enzymes, Polymerases, Ligases
6) By Recombinant Regulatory Proteins: Transcription Factors, Receptors, Hormones
7) By Hormones: Insulin, Growth Hormones
8) By Other Products: Fusion Proteins, Peptide Therapeutics
How Are Market Trends Influencing Competition In The Recombinant Proteins Market?
The increased emphasis on product innovation is a dominant trend emerging within the recombinant protein market. Many established companies within this field are seeking to fortify their market position through the introduction of unique and innovative products. For example, ProteoGenix, a biochemical company based in France, introduced the XtenCHO Transient CHO Expression System, a strategic development aimed to bolster biologics development, in March 2022. This recent system provides multiple benefits, inclusive of tenfold enhanced yields, enhanced plasmid stability and efficient procedures requiring minimal hands-on time. The XtenCHO system is projected to offer a rapid and budget-friendly solution, making it perfectly suited for both bioanalytical applications and drug development scenarios.
Which Firms Are Making The Biggest Impact In The Recombinant Proteins Market?
Major companies operating in the recombinant proteins market include Abcam plc, Abnova Corporation, Bio-Rad Laboratoroies Inc., Merck Co. & KGaA, R&D Systems Inc., Proteintech Group Inc., RayBiotech Life Inc., GenScript Biotech Corporation, Elpiscience Biopharmaceuticals Co. Ltd., Elevian Inc., Gigagen Inc., Janssen- Cilag Pvt. Ltd., Sino Biological Inc., OriGene Technologies Inc., Feldan Therapeutics Inc., Randox Laboratories Ltd., Bio-Techne Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Crown Bioscience Inc., Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Eli Lilly and Company
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/recombinant-proteins-global-market-report
Which Region Holds The Greatest Opportunity For Recombinant Proteins Market Expansion?
North America was the largest region in the recombinant protein market in 2024. The regions covered in the recombinant proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=9959&type=smp
Browse Through More Reports Similar to the Global Recombinant Proteins Market 2025, By The Business Research Company
Hair Preparations Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hair-preparations-global-market-report
Natural Hair Care Products Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/natural-hair-care-products-global-market-report
Luxury Hair Care Products Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/luxury-hair-care-products-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
